Cozad Asset Management’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-74,675
Closed -$3.25M 364
2021
Q4
$3.25M Sell
74,675
-206
-0.3% -$8.08K 0.46% 57
2021
Q3
$2.34M Sell
74,881
-5,376
-7% -$212K 0.37% 75
2021
Q2
$3.4M Sell
80,257
-24,798
-24% -$965K 0.53% 52
2021
Q1
$3.95M Buy
105,055
+3,051
+3% +$95.4K 0.64% 42
2020
Q4
$2.76M Sell
102,004
-87,717
-46% -$2.26M 0.49% 52
2020
Q3
$4.76M Sell
189,721
-10,459
-5% -$153K 0.9% 32
2020
Q2
$1.52M Buy
200,180
+7,910
+4% +$57.9K 0.31% 93
2020
Q1
$1.76M Buy
+192,270
New +$1.16M 0.61% 47

Other funds holding ACH

Cozad Asset Management's ACH Position: Q1 2022 in Review

Cozad Asset Management sold out of Accendra Health (ACH) in Q1 2022, closing a stake of 74,675 shares — an estimated $3.25M sold.

Cozad Asset Management first reported a position in ACH in Q1 2020 and held it in 8 quarters. The position peaked at $4.76M in Q3 2020. 266 funds tracked by Wall St. Rank hold ACH as of Q1 2022.

  • Cozad Asset Management reported no remaining Accendra Health position as of Q1 2022 after selling out during the quarter.
  • Cozad Asset Management sold 74,675 Accendra Health shares in Q1 2022, an estimated $3.25M.
  • Cozad Asset Management first reported a position in Accendra Health in Q1 2020 and held it in 8 quarters.
  • Cozad Asset Management's Accendra Health position peaked at $4.76M in Q3 2020.
  • 266 funds tracked by Wall St. Rank held Accendra Health as of Q1 2022.

Based on Cozad Asset Management's 13F filing for Q1 2022, filed 29 Apr 2022.